Medicosnext

Pfizer and BioNTech’s COVID-19 vaccine has been authorized for emergency use in the United Kingdom, which has ordered 40 million doses, enough for 20 million people, since two doses are required for each individual. The government expects to receive 10 million doses before the end of the year. The developers …

The pioneer medial educationist talks to Medicos Next about his career and medical education in Nepal as he retires from his post at Nepal Medical College after over 24 years of service in July this year.   Dr. Shekhar Babu Rizyal, Former Director Medical Education Dept., Nepal Medical College, did …

Siberia’s Vector Research Center has claimed that all volunteers vaccinated by its COVID-19 vaccine, EpiVacCorona, developed antibodies, although the first two phases of testing involved only 100 volunteers. The center reported, “Clinical studies have shown that antibodies were detected in 100% of the volunteers immunized with the EpiVacCorona vaccine, Most …

Turkish Airlines has started its operations worldwide and is proud to welcome its passengers to Turkey and beyond destinations with all health and international safety protocols. Turkish Airlines in Kathmandu currently operates 3 weekly flights to and from Istanbul and beyond. Globally, the airlines has started operating to over 206 …

After reviewing the results of the RECOVERY study arm involving use of dexamethasone in the treatment of hospitalized COVID-19 patients, the European Medicines Agency (EMA) has concluded that dexamethasone can be considered a treatment option for patients requiring oxygen therapy (from supplemental oxygen to mechanical ventilation). EMA is endorsing the …

Even though the World Health Organization has published the largest randomized trial showing that remdesivir showed no benefit on reducing hospital stays or mortality, the drug has been approved by the U.S. FDA for standard of care use for hospitalized COVID-19 patients. The approval was based on a study by …

Roche and Atea Pharmaceutical are collaborating to develop, manufacture, and distribute Atea’s investigational oral direct-acting antiviral AT-527, which acts by blocking the viral RNA polymerase enzyme needed for viral replication. It is currently undergoing phase 2 clinical trial for hospitalized patients with moderate COVID-19, with phase 3 clinical trial expected …

Japanese drug maker Takeda has entered into collaboration with Massachusetts biotech Moderna to bring 50 million doses of its mRNA-based COVID-19 shots to Japanese shores. Takeda will import and distribute mRNA-1273 starting in the first half of 2021, besides handling local regulatory approvals. Moderna’s vaccine is currently undergoing a 30,000-patient …

Menopause is defined as the time a woman has experienced 12 months of amenorrhea, and hence, permanent cessation of menstrual cycles. Natural menopause, occurring at a median age of 51.4 years, results from the depletion of ovarian follicular activity. This depletion reflects physiologically with decrease in hormone production by the …

Many biotech companies and researchers have developed new testing methods to detect SARS-CoV-2 in order to cut backlogs and increase the accessibility of testing. At the moment, nucleic acid amplification testing (PCR/RT-PCR) is the most widely used platform to detect SARS-CoV-2. It is a gold standard test with high levels …